mRNA flu vaccines are in clinical trials, with some outlets reporting that a version developed by Moderna has shown effectiveness in late-stage trials. However, there are conflicting reports about the FDA's stance on reviewing Moderna's mRNA flu vaccine application, with some outlets stating that the FDA has agreed to review it and others stating that the FDA has refused. The status of the FDA's review of Moderna's mRNA flu vaccine remains unclear.